- Home
- CCCC vs FFNW Comparison
CCCC vs FFNW Comparison
Compare CCCC & FFNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- FFNW
- Stock Information
- Founded
- CCCC 2015
- FFNW 1923
- Country
- CCCC United States
- FFNW United States
- Employees
- CCCC N/A
- FFNW N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- FFNW Banks
- Sector
- CCCC Health Care
- FFNW Finance
- Exchange
- CCCC Nasdaq
- FFNW Nasdaq
- Market Cap
- CCCC 244.9M
- FFNW 203.8M
- IPO Year
- CCCC 2020
- FFNW N/A
- Fundamental
- Price
- CCCC $3.01
- FFNW $21.43
- Analyst Decision
- CCCC Buy
- FFNW Hold
- Analyst Count
- CCCC 5
- FFNW 2
- Target Price
- CCCC $11.60
- FFNW $22.75
- AVG Volume (30 Days)
- CCCC 1.8M
- FFNW 17.6K
- Earning Date
- CCCC 03-04-2025
- FFNW 01-28-2025
- Dividend Yield
- CCCC N/A
- FFNW 1.21%
- EPS Growth
- CCCC N/A
- FFNW N/A
- EPS
- CCCC N/A
- FFNW 0.12
- Revenue
- CCCC $33,668,000.00
- FFNW $37,609,000.00
- Revenue This Year
- CCCC $75.59
- FFNW N/A
- Revenue Next Year
- CCCC N/A
- FFNW $0.82
- P/E Ratio
- CCCC N/A
- FFNW $183.59
- Revenue Growth
- CCCC 65.45
- FFNW N/A
- 52 Week Low
- CCCC $2.79
- FFNW $20.10
- 52 Week High
- CCCC $11.88
- FFNW $23.50
- Technical
- Relative Strength Index (RSI)
- CCCC 33.55
- FFNW 50.18
- Support Level
- CCCC $2.79
- FFNW $21.32
- Resistance Level
- CCCC $3.38
- FFNW $21.61
- Average True Range (ATR)
- CCCC 0.20
- FFNW 0.23
- MACD
- CCCC -0.03
- FFNW 0.01
- Stochastic Oscillator
- CCCC 23.66
- FFNW 54.43
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.
About FFNW First Financial Northwest Inc.
First Financial Northwest Inc is the holding company. The Bank's business consists predominantly of attracting deposits from the general public, combined with borrowing from the FHLB of Des Moines and raising funds in the wholesale market then utilizing these funds to originate one-to-four family residential, multifamily, commercial real estate, construction/land, business, and consumer loans. The Bank's strategic initiatives seek to diversify its loan portfolio and broaden growth opportunities with its current risk tolerance levels and asset/liability objectives.